Skip to main content

Advertisement

Log in

Multilocular sinonasal malignant melanoma: a poor prognostic subgroup?

  • Rhinology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Clinical observations show that two subtypes of sinonasal malignant melanoma exist: uni- and multilocular melanoma. The aim of this retrospective study was to determine the prevalence and outcome of multilocular sinonasal malignant melanoma. All patients with sinonasal malignant melanoma treated at our institution between 1992 and 2011 were included. Survival and recurrence data were analyzed related to the distribution pattern of the tumors and other factors. Twenty-five patients were identified and included in the analysis. Seven patients (28 %) suffered from multilocular, the remaining 18 patients (72 %) from unilocular sinonasal malignant melanoma. The first group showed a significantly worse disease-free survival, whereas disease-specific and overall survival did not differ between the two subtypes. Multilocular sinonasal malignant melanoma is associated with an unfavorable disease-free survival compared to its unilocular counterpart.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lund VJ, Howard DJ, Harding L, Wei WI (1999) Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 109:208–211

    Article  CAS  PubMed  Google Scholar 

  2. Lund VJ, Chisholm EJ, Howard DJ, Wei WI (2012) Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology 50:203–210

    CAS  PubMed  Google Scholar 

  3. Bachar G, Loh KS, O’Sullivan B, Goldstein D, Wood S, Brown D et al (2008) Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck 30:1325–1331

    Article  PubMed  Google Scholar 

  4. Keller DS, Thomay AA, Gaughan J, Olszanski A, Wu H, Berger AC et al (2013) Outcomes in patients with mucosal melanomas. J Surg Oncol. doi:10.1002/jso.23445

    Google Scholar 

  5. Roth TN, Gengler C, Huber GF, Holzmann D (2010) Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck 32:1385–1392

    Article  PubMed  Google Scholar 

  6. Mendenhall WM, Amdur RJ, Hinerman RW, Werning JW, Villaret DB, Mendenhall NP (2005) Head and neck mucosal melanoma. Am J Clin Oncol 28:626–630

    Article  PubMed  Google Scholar 

  7. Kingston NJ, Jones RW, Baranyai J (2004) Recurrent primary vulvovaginal malignant melanoma arising in melanoma in situ—the natural history of lesions followed for 23 years. Int J Gynecol Cancer 14:628–632

    Article  CAS  PubMed  Google Scholar 

  8. Lotem M, Anteby S, Peretz T, Ingber A, Avinoach I, Prus D (2003) Mucosal melanoma of the female genital tract is a multifocal disorder. Gynecol Oncol 88:45–50

    Article  PubMed  Google Scholar 

  9. Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M et al (2010) Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer 116:2215–2223

    PubMed  Google Scholar 

  10. Krengli M, Jereczek-Fossa BA, Kaanders JH, Masini L, Beldì D, Orecchia R (2008) What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck? Crit Rev Oncol Hematol 65:121–128

    Article  PubMed  Google Scholar 

  11. Owens JM, Roberts DB, Myers JN (2003) The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 129:864–868

    Article  PubMed  Google Scholar 

  12. Bridger AG, Smee D, Baldwin MA, Kwok B, Bridger GP (2005) Experience with mucosal melanoma of the nose and paranasal sinuses. ANZ J Surg 75:192–197

    Article  PubMed  Google Scholar 

  13. Temam S, Mamelle G, Marandas P, Wibault P, Avril MF, Janot F et al (2005) Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 103:313–319

    Article  PubMed  Google Scholar 

  14. Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH et al (2002) Primary mucosal malignant melanoma of the head and neck. Head Neck 24:247–257

    Article  PubMed  Google Scholar 

  15. Dauer EH, Lewis JE, Rohlinger AL, Weaver AL, Olsen KD (2008) Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg 138:347–352

    Article  PubMed  Google Scholar 

  16. Prasad ML, Busam KJ, Patel SG, Hoshaw-Woodard S, Shah JP, Huvos AG (2003) Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract. Arch Pathol Lab Med 127:997–1002

    PubMed  Google Scholar 

  17. Koivunen P, Bäck L, Pukkila M, Laranne J, Kinnunen I, Grénman R et al (2012) Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma. Laryngoscope 122:1734–1738

    Article  PubMed  Google Scholar 

  18. Thompson LD, Wieneke JA, Miettinen M (2003) Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 27:594–611

    Article  PubMed  Google Scholar 

  19. Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran ND et al (2013) Fast neutron radiotherapy for primary mucosal melanomas of the head and neck. Head Neck. doi:10.1002/hed.23428

    Google Scholar 

  20. Haerle SK, Soyka MB, Fischer DR, Murer K, Strobel K, Huber GF et al (2012) The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma. Eur Arch Otorhinolaryngol 269:127–133

    Article  CAS  PubMed  Google Scholar 

  21. Cohen Y, Rosenbaum E, Begum S, Goldenberg D, Esche C, Lavie O et al (2004) Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res 10:3444–3447

    Article  CAS  PubMed  Google Scholar 

  22. Curtin JA, Busam K, Pinkel D, Bastian BC (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340–4346

    Article  CAS  PubMed  Google Scholar 

  23. Went PT, Dirnhofer S, Bundi M, Mirlacher M, Schraml P, Mangialaio S et al (2004) Prevalence of KIT expression in human tumors. J Clin Oncol 22:4514–4522

    Article  CAS  PubMed  Google Scholar 

  24. Hersey P, Bastholt L, Chiarion-Sileni V, Cinat G, Dummer R, Eggermont AM et al (2009) Small molecules and targeted therapies in distant metastatic disease. Ann Oncol 20(Suppl 6):vi35–vi40

    Article  PubMed Central  PubMed  Google Scholar 

  25. Ugurel S, Hildenbrand R, Zimpfer A, La Rosée P, Paschka P, Sucker A et al (2005) Lack of clinical efficacy of imatinib in metastatic melanoma. Br J Cancer 92:1398–1405

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Wyman K, Atkins MB, Prieto V, Eton O, McDermott DF, Hubbard F et al (2006) Multicenter phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy. Cancer 106:2005–2011

    Article  CAS  PubMed  Google Scholar 

  27. Satzger I, Küttler U, Völker B, Schenck F, Kapp A, Gutzmer R (2010) Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy—case report and review of the literature. Dermatology 220:77–81

    Article  PubMed  Google Scholar 

  28. Mocellin S, Lens MB, Pasquali S, Pilati P, Chiarion Sileni V (2013) Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev. doi:10.1002/14651858.CD008955.pub2

    PubMed  Google Scholar 

  29. Papaspyrou G, Garbe C, Schadendorf D, Werner JA, Hauschild A, Egberts F (2011) Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Melanoma Res 21:475–482

    Article  CAS  PubMed  Google Scholar 

  30. Gore MR, Zanation AM (2012) Survival in sinonasal melanoma: a meta-analysis. J Neurol Surg B Skull Base 73:157–162

    Article  PubMed Central  PubMed  Google Scholar 

  31. McLean N, Tighiouart M, Muller S (2008) Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol 44:1039–1046

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Domenic Vital.

Additional information

O. Stanimirov Rossi and D. Vital contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stanimirov Rossi, O., Vital, D., Soyka, M.B. et al. Multilocular sinonasal malignant melanoma: a poor prognostic subgroup?. Eur Arch Otorhinolaryngol 272, 123–129 (2015). https://doi.org/10.1007/s00405-014-3098-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-014-3098-z

Keywords

Navigation